Literature DB >> 23122636

Cocaine abuse or dependency and other pyschiatric disorders. Madrid study on dual pathology.

Francisco Arias1, Nestor Szerman, Pablo Vega, Beatriz Mesias, Ignacio Basurte, Consuelo Morant, Enriqueta Ochoa, Félix Poyo, Francisco Babin.   

Abstract

OBJECTIVES: The main objective of this study was to analyse the cocaine addict subgroup from the Madrid study of prevalence of dual disorders in community mental health and substance misuse services.
MATERIAL AND METHODS: The sample consisted of 837 outpatients from Madrid, Spain. We compared 488 subjects who had a lifetime diagnosis of cocaine abuse or dependence, and 222 subjects who did not have a cocaine substance use disorder. We used the Mini International Neuropsychiatric Interview to evaluate axis I mental disorders, and the Personality Disorder Questionnaire to evaluate personality disorders.
RESULTS: Almost three-quarters (73.4%) of cocaine addicts had a current dual disorder. Most prevalent were mood and anxiety disorders. Almost half (49.6%) had a personality disorder. Most of them (94.9%) had other substance use disorders. Cocaine addicts did not have higher prevalence rates of dual pathology than addicts with no cocaine abuse or dependence. Cocaine addicts were associated to a diagnosis of antisocial personality disorder, agoraphobia, and post-traumatic stress disorder, and they had an early age of onset of alcohol and cannabis use.
CONCLUSIONS: Dual pathology is no higher in cocaine addicts in treatment than in addicts who do not use cocaine, however cocaine addicts started other drugs earlier, and were associated with specific mental disorders.
Copyright © 2012 SEP y SEPB. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23122636     DOI: 10.1016/j.rpsm.2012.09.002

Source DB:  PubMed          Journal:  Rev Psiquiatr Salud Ment        ISSN: 1888-9891            Impact factor:   3.318


  7 in total

1.  Examining Risk for Frequent Cocaine Use: Focus on an African American Treatment Population.

Authors:  Tamika Chere Barkley Zapolski; Patrick Baldwin; Carl W Lejuez
Journal:  Subst Use Misuse       Date:  2016-04-21       Impact factor: 2.164

2.  Sex differences in the long-lasting consequences of adolescent ethanol exposure for the rewarding effects of cocaine in mice.

Authors:  A Mateos-García; C Manzanedo; M Rodríguez-Arias; M A Aguilar; E Reig-Sanchis; C I Navarro-Francés; O Valverde; J Miñarro; M C Arenas
Journal:  Psychopharmacology (Berl)       Date:  2015-05-06       Impact factor: 4.530

Review 3.  Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence.

Authors:  Lauren Kuhns; Emese Kroon; Karis Colyer-Patel; Janna Cousijn
Journal:  Psychopharmacology (Berl)       Date:  2021-11-06       Impact factor: 4.415

4.  Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice.

Authors:  María A Aguilar; Juan Carlos Ledesma; Marta Rodríguez-Arias; Carles Penalva; Carmen Manzanedo; José Miñarro; M Carmen Arenas
Journal:  Int J Mol Sci       Date:  2017-06-21       Impact factor: 5.923

5.  Adolescent but not adult ethanol binge drinking modulates cocaine withdrawal symptoms in mice.

Authors:  Juan Carlos Ledesma; Maria A Aguilar; Pablo Giménez-Gómez; José Miñarro; Marta Rodríguez-Arias
Journal:  PLoS One       Date:  2017-03-14       Impact factor: 3.240

6.  Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study.

Authors:  Beatriz Puértolas-Gracia; María Gabriela Barbaglia; Mercè Gotsens; Oleguer Parés-Badell; María Teresa Brugal; Marta Torrens; Lara Treviño; Concepción Rodríguez-Díaz; José María Vázquez-Vázquez; Alicia Pascual; Marcela Coromina-Gimferrer; Míriam Jiménez-Dueñas; Israel Oliva; Erick González; Nicanor Mestre; Montse Bartroli
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

7.  Professionals' perception on the management of patients with dual disorders.

Authors:  Carlos Roncero; Néstor Szerman; Antonio Terán; Carlos Pino; José María Vázquez; Elena Velasco; Marta García-Dorado; Miguel Casas
Journal:  Patient Prefer Adherence       Date:  2016-09-19       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.